General Information of the Compound
Compound ID
CP0498355
Compound Name
6-(5-bromopyridin-3-yl)-4,4-dimethyl-1H-3,1-benzoxazine-2-thione
    Show/Hide
Structure
Formula
C15H13BrN2OS
Molecular Weight
349.253
Canonical SMILES
CC1(C)OC(=S)Nc2ccc(cc12)-c1cncc(Br)c1
    Show/Hide
InChI
InChI=1S/C15H13BrN2OS/c1-15(2)12-6-9(10-5-11(16)8-17-7-10)3-4-13(12)18-14(20)19-15/h3-8H,1-2H3,(H,18,20)
    Show/Hide
InChIKey
GHELUGIZMVFOKT-UHFFFAOYSA-N
Physicochemical Property
logP
4.4732
Rotatable Bonds
1
Heavy Atom Count
20
Polar Areas
34.15
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Complexity
20

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 10472986
SID: 15496500
ChEMBL ID
CHEMBL25556
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01172, Progesterone receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000078 T-47D Homo sapiens (Human)  1
1
EC50 = 5.7 nM
   TI
   LI
   LO
   TS